Vericel Corp (NAS:VCEL)
$ 50.13 -1.4 (-2.72%) Market Cap: 2.44 Bil Enterprise Value: 2.49 Bil PE Ratio: 9,999.00 PB Ratio: 10.40 GF Score: 79/100

Vericel Corp at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2020 / 07:45PM GMT
Release Date Price: $24.18 (+7.56%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Hi. Good afternoon, everybody, and thanks so much for joining us. I'm here -- I'm very pleased to be here with Nick Colangelo, President and CEO of Vericel.

And I'm going to turn it over to Nick to give a brief introduction. Take as much time as you like, but optimally enough time to leave the majority of the session for questions.

But -- so with that, Nick, thank you, and I'll turn it over to you.

Dominick C. Colangelo
Vericel Corporation - CEO, President & Director

Well, thanks, Matt. It's a pleasure to be here today. So I was just going to review a few introductory slides regarding the company. That's maybe 5 to 10 minutes, and then we'll leave the rest of the session for question and answers.

And before I begin, I'd just like to remind everyone that this presentation and my comments contain forward-looking statements, so you should refer to our documents on file with the SEC for further information.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot